This inventor holds 3 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1989-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-1990
Title: Kunihito Okumura: Innovator in Benzoxazole Derivatives
Introduction
Kunihito Okumura is a notable inventor based in Urawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on benzoxazole derivatives. With a total of 3 patents to his name, Okumura's innovations are paving the way for new therapeutic agents.
Latest Patents
Okumura's latest patents focus on novel benzoxazole derivatives that have potential applications in treating diabetes. The first patent describes benzoxazole derivatives characterized by specific structural formulas, where R can be a substituted or unsubstituted phenyl group, naphthyl group, cycloalkyl group, or heterocyclic group. The derivatives and their pharmaceutically acceptable salts are disclosed as useful therapeutic agents for diabetes. The second patent similarly outlines another novel benzoxazole derivative with the same structural characteristics, emphasizing its utility in diabetes treatment.
Career Highlights
Kunihito Okumura is currently associated with Tanabe Seiyaku Company, Limited, where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in developing new compounds that can significantly impact diabetes management.
Collaborations
Okumura has collaborated with esteemed colleagues such as Ikuo Iijima and Masakatsu Ozeki. Their combined expertise has contributed to the advancement of research in medicinal chemistry.
Conclusion
Kunihito Okumura's contributions to the field of benzoxazole derivatives highlight his role as a key innovator in pharmaceutical research. His work not only showcases his inventive spirit but also holds promise for future therapeutic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile